{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:50:29Z","timestamp":1785880229662,"version":"3.56.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1452300"],"award-info":[{"award-number":["23ZR1452300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117054","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:04:54Z","timestamp":1782216294000},"page":"117054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the spatial-metabolic-immune ecosystem in colorectal Cancer liver metastasis: pharmacological strategies and the \u201cbreak-normalize-reset\u201d paradigm"],"prefix":"10.1016","volume":"185","author":[{"given":"Jia","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117054_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clinicians."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12967-024-05994-y","article-title":"Mfsd2a suppresses colorectal cancer progression and liver metastasis via the S100A14\/STAT3 axis","volume":"23","author":"Sun","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0015","first-page":"451","article-title":"Immune checkpoint inhibitors: breakthroughs in cancer treatment","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0020","article-title":"Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2026.117054_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.46094","article-title":"Liver metastases and immune checkpoint inhibitor efficacy in patients with refractory metastatic colorectal cancer: a secondary analysis of a randomized clinical trial","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12916-023-02866-y","article-title":"Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability","volume":"21","author":"Wu","year":"2023","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.intimp.2026.117054_bb0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2026.117054_bb0040","first-page":"1409","article-title":"Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms","volume":"5","author":"Chu","year":"2024","journal-title":"Nat. Can."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/cancers16010059","article-title":"Multilevel heterogeneity of colorectal cancer liver metastasis","volume":"16","author":"Chen","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.intimp.2026.117054_bb0055","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"8","author":"Paget","year":"1889","journal-title":"Cancer Metastasis Rev. 1989"},{"issue":"7069","key":"10.1016\/j.intimp.2026.117054_bb0060","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2026.117054_bb0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","article-title":"Immune determinants of the pre-metastatic niche","volume":"41","author":"Patras","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2026.117054_bb0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00018-022-04630-6","article-title":"Mechanisms of colorectal liver metastasis development","volume":"79","author":"Shasha","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s10020-025-01112-w","article-title":"Cancer-secreted exosomal miR-1246 promotes colorectal cancer liver metastasis by activating hepatic stellate cells","volume":"31","author":"Liu","year":"2025","journal-title":"Mol Med (camb Mass,)."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12967-025-06334-4","article-title":"Colorectal cancer cells-derived exosomal miR-188-3p promotes liver metastasis by creating a pre-metastatic niche via activation of hepatic stellate cells","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02086-9","article-title":"Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1highCD206+ pro-tumor macrophages mediated pre-metastatic niche formation in colorectal cancer liver metastasis","volume":"23","author":"Zhou","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-024-01052-3","article-title":"Cholestasis-induced phenotypic transformation of neutrophils contributes to immune escape of colorectal cancer liver metastasis","volume":"31","author":"Sun","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2026.117054_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-334851","article-title":"Extracellular vesicle-induced lipid dysregulation drives liver premetastatic niche formation in colorectal cancer","author":"Cao","year":"2025","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.intimp.2026.117054_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.gastro.2022.11.029","article-title":"Integrated multi-omics landscape of liver metastases","volume":"164","author":"Yang","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0120","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8+T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2026.117054_bb0125","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.intimp.2026.117054_bb0130","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1158\/2159-8290.CD-24-0708","article-title":"The journey of antibody-drug conjugates: lessons learned from 40 years of development","volume":"14","author":"Colombo","year":"2024","journal-title":"Cancer Discov."},{"issue":"23","key":"10.1016\/j.intimp.2026.117054_bb0135","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.3748\/wjg.v29.i23.3606","article-title":"BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells","volume":"29","author":"Jiang","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0140","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1038\/s41467-025-60575-x","article-title":"stClinic dissects clinically relevant niches by integrating spatial multi-slice multi-omics data in dynamic graphs","volume":"16","author":"Zuo","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1158\/1078-0432.CCR-22-2041","article-title":"Colorectal cancer metastases in the liver establish immunosuppressive spatial networking between tumor-associated SPP1+ macrophages and fibroblasts","volume":"29","author":"Sathe","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-02991-3","article-title":"Tumor-derived exosomal ADAM17 promotes pre-metastatic niche formation by enhancing vascular permeability in colorectal cancer","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117054_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127392","article-title":"Indole metabolites and colorectal cancer: gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms","volume":"272","author":"Liu","year":"2023","journal-title":"Microbiol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s10020-025-01099-4","article-title":"Harnessing amino acid pathways to influence myeloid cell function in tumor immunity","volume":"31","author":"Pan","year":"2025","journal-title":"Mol Med (camb Mass,)."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117054_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trsl.2024.04.003","article-title":"Targeting the devil: strategies against cancer-associated fibroblasts in colorectal cancer","volume":"270","author":"Chen","year":"2024","journal-title":"Transl Res: J Lab Clin Med."},{"issue":"7931","key":"10.1016\/j.intimp.2026.117054_bb0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.intimp.2026.117054_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf5464","article-title":"Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"issue":"5795","key":"10.1016\/j.intimp.2026.117054_bb0200","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2026.117054_bb0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","article-title":"Lactate: a key regulator of the immune response","volume":"58","author":"Llibre","year":"2025","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2026.117054_bb0210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.117054_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics?","volume":"90","author":"Singh","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.117054_bb0220","article-title":"Current perspectives and trends of CD39-CD73-eAdo\/A2aR research in tumor microenvironment: a bibliometric analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.62347\/ZSOO2247","article-title":"Role of amino acid metabolism in tumor immune microenvironment of colorectal cancer","volume":"15","author":"Zhu","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"Pt B","key":"10.1016\/j.intimp.2026.117054_bb0230","article-title":"Wumei wan remodels the tumor immune microenvironment via the Ido1-KYN-AHR axis in AOM\/DSS-induced colorectal cancer model","volume":"353","author":"Zhang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.117054_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216120","article-title":"Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation","volume":"559","author":"Coni","year":"2023","journal-title":"Cancer Lett."},{"issue":"36","key":"10.1016\/j.intimp.2026.117054_bb0240","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/s41388-025-03495-w","article-title":"Glutaminase as a metabolic target of choice to counter acquired resistance to palbociclib by colorectal cancer cells","volume":"44","author":"Tarrado-Castellarnau","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0245","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41598-024-84801-6","article-title":"The effect of fecal bile acids on the incidence and risk-stratification of colorectal cancer: an updated systematic review and meta-analysis","volume":"15","author":"Yang","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12944-022-01705-y","article-title":"Lipid metabolic features of T cells in the tumor microenvironment","volume":"21","author":"Lou","year":"2022","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13578-023-00977-w","article-title":"Metabolic reprogramming in colorectal cancer: regulatory networks and therapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-023-02832-9","article-title":"Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming","volume":"42","author":"Zeng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02729-7","article-title":"Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.117054_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121977","article-title":"Inhibition of PCSK9 attenuates liver endothelial cell activation induced by colorectal cancer stem cells during liver metastasis","volume":"17","author":"Martin","year":"2025","journal-title":"Cancers"},{"issue":"25","key":"10.1016\/j.intimp.2026.117054_bb0275","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41388-025-03458-1","article-title":"Immunometabolism of regulatory T cells in cancer","volume":"44","author":"Saravia","year":"2025","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0280","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.7150\/thno.105276","article-title":"Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0290","article-title":"Glucagon enhances chemotherapy efficacy by inhibition of tumor vessels in colorectal Cancer","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"issue":"8","key":"10.1016\/j.intimp.2026.117054_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081822","article-title":"How chemotherapy affects the tumor immune microenvironment: a narrative review","volume":"10","author":"Merlano","year":"2022","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.intimp.2026.117054_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16183158","article-title":"Cancer-associated fibroblast proteins as potential targets against colorectal cancers","volume":"16","author":"Shah","year":"2024","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.intimp.2026.117054_bb0305","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180802","article-title":"Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment","volume":"135","author":"Yang","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2026.117054_bb0310","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","article-title":"Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade","volume":"42","author":"Nabet","year":"2024","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.intimp.2026.117054_bb0315","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","article-title":"Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5706","key":"10.1016\/j.intimp.2026.117054_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Sci (N Y NY)."},{"key":"10.1016\/j.intimp.2026.117054_bb0325","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.2147\/OTT.S307273","article-title":"Subgroup analysis by liver metastasis in the FRESCO trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer","volume":"14","author":"Qin","year":"2021","journal-title":"Onco. Targets Ther."},{"issue":"3","key":"10.1016\/j.intimp.2026.117054_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008409","article-title":"Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial","volume":"12","author":"Lenz","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117054_bb0335","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2147\/IJN.S402821","article-title":"Lipid nanoparticles-based therapy in liver metastasis management: from tumor cell-directed strategy to liver microenvironment-directed strategy","volume":"18","author":"Wang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.intimp.2026.117054_bb0340","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/acsnano.3c11436","article-title":"An oral nanomedicine elicits in situ vaccination effect against colorectal cancer","volume":"18","author":"Zu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117054_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217091","article-title":"MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy","volume":"598","author":"Richiardone","year":"2024","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.intimp.2026.117054_bb0350","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117054_bb0355","article-title":"Lactate-related metabolic reprogramming and immune regulation in colorectal cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117054_bb0360","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","article-title":"First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors","volume":"72","author":"Bendell","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2026.117054_bb0365","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010126","article-title":"Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation","volume":"13","author":"Sun","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.117054_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6980","article-title":"PD-1 inhibition with retifanlimab and\/or arginase inhibition with INCB001158 in japanese patients with solid tumors: a phase I study","volume":"13","author":"Kuboki","year":"2024","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117054_bb0375","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00262-024-03925-w","article-title":"IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization","volume":"74","author":"Guangzhao","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0380","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/cas.70057","article-title":"Epacadostat overcomes cetuximab resistance in colorectal cancer by targeting IDO-mediated tryptophan metabolism","volume":"116","author":"Zhou","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2026.117054_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2024.104896","article-title":"Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model","volume":"137","author":"Miyamoto","year":"2024","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.intimp.2026.117054_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114829","article-title":"Bile acids produced by gut microbiota activate TGR5 to promote colorectal liver metastasis progression by inducing MDSCs infiltration in liver","volume":"158","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0395","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2217024","article-title":"FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer","volume":"12","author":"Lu","year":"2023","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0400","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03154-0","article-title":"Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPAR\u03b3-driven lipid biosynthesis via regulating lipidome metabolic reprogramming","volume":"43","author":"Shan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.117054_bb0405","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/cac2.12341","article-title":"PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism","volume":"42","author":"Dai","year":"2022","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0410","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41420-022-01241-9","article-title":"Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis","volume":"8","author":"Han","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.117054_bb0415","article-title":"Concomitant NAFLD facilitates liver metastases and PD-1-refractory by recruiting MDSCs via CXCL5\/CXCR2 in colorectal cancer","volume":"18","author":"Yang","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117054_bb0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00262-024-03779-2","article-title":"Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature","volume":"73","author":"Xu","year":"2024","journal-title":"Cancer Immunol Immunother: CII."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0425","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41467-023-37229-x","article-title":"Blocking dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"issue":"731","key":"10.1016\/j.intimp.2026.117054_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1834","article-title":"The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers","volume":"16","author":"Voissi\u00e8re","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.117054_bb0435","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/cac2.70047","article-title":"Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis","volume":"45","author":"Zhan","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.intimp.2026.117054_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1485303","article-title":"Efficacy and safety of PD-1\/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis","volume":"15","author":"Song","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0445","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01574-1","article-title":"Lipid-based nanosystems: the next generation of cancer immune therapy","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"8024","key":"10.1016\/j.intimp.2026.117054_bb0450","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","article-title":"Tumour vasculature at single-cell resolution","volume":"632","author":"Pan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117054_bb0455","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/ITT.S494670","article-title":"Immune checkpoint inhibitor combined with antiangiogenic agent synergistically improving the treatment efficacy for solid tumors","volume":"13","author":"Zhou","year":"2024","journal-title":"ImmunoTargets Ther."},{"issue":"8","key":"10.1016\/j.intimp.2026.117054_bb0460","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.intimp.2026.117054_bb0465","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181374","article-title":"68Ga-FAPI PET imaging monitors response to combined TGF-\u03b2R inhibition and immunotherapy in metastatic colorectal cancer","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.intimp.2026.117054_bb0470","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","article-title":"Spatial omics and multiplexed imaging to explore cancer biology","volume":"18","author":"Lewis","year":"2021","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.intimp.2026.117054_bb0475","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cmet.2022.06.012","article-title":"Integrating multiplex immunofluorescent and mass spectrometry imaging to map myeloid heterogeneity in its metabolic and cellular context","volume":"34","author":"Goossens","year":"2022","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.intimp.2026.117054_bb0480","article-title":"Integrative proteomic profiling of tumor and plasma extracellular vesicles identifies a diagnostic biomarker panel for colorectal cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep, Med."},{"key":"10.1016\/j.intimp.2026.117054_bb0485","article-title":"Exploring the role of gut microbiota in colorectal liver metastasis through the gut-liver axis","volume":"13","author":"Liu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117054_bb0490","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2025.04.001","article-title":"Decoding the neuroimmune axis in colorectal cancer: from neural circuitry to therapeutic innovation","volume":"83","author":"Li","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.117054_bb0495","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1038\/s41598-025-89152-4","article-title":"Decoupling chemical and mechanical signaling in colorectal cancer cell migration","volume":"15","author":"Tetrick","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0500","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","article-title":"High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer","volume":"57","author":"Oliveira","year":"2025","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0505","first-page":"618","article-title":"Multi-omics in colorectal cancer liver metastasis: applications and research advances","volume":"22","author":"Zhou","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117054_bb0510","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.21037\/jgo-23-862","article-title":"Significant response from fruquintinib plus anti-PD-1 immunotherapy for microsatellite stable metastatic colorectal cancer with liver and lung metastasis in the third line: case report","volume":"14","author":"He","year":"2023","journal-title":"J Gastrointest Oncol."},{"issue":"19","key":"10.1016\/j.intimp.2026.117054_bb0515","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1158\/1078-0432.CCR-17-3284","article-title":"Parallel accumulation of tumor hyaluronan, collagen, and other drivers of tumor progression","volume":"24","author":"Li","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"16_suppl","key":"10.1016\/j.intimp.2026.117054_bb0520","doi-asserted-by":"crossref","first-page":"TPS3638","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3638","article-title":"STOPTRAFFIC-1: a phase I\/II trial of SX-682 in combination with nivolumab for refractory RAS-mutated microsatellite stable (MSS) metastatic colorectal cancer (mCRC)","volume":"40","author":"Johnson","year":"2022","journal-title":"J. Clin. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:28:46Z","timestamp":1785878926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":104,"alternative-id":["S1567576926009008"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117054","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the spatial-metabolic-immune ecosystem in colorectal Cancer liver metastasis: pharmacological strategies and the \u201cbreak-normalize-reset\u201d paradigm","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117054"}}